CREDIT SUISSE AG/ - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CONMED CORP
ValueSharesWeighting
Q1 2024$4,222,138
-49.0%
52,724
-30.3%
0.00%
-50.0%
Q4 2023$8,285,964
+2.1%
75,664
-6.0%
0.01%0.0%
Q3 2023$8,118,324
-26.5%
80,499
-0.9%
0.01%
-27.3%
Q2 2023$11,043,508
-16.0%
81,268
-35.8%
0.01%
-15.4%
Q1 2023$13,153,973
+19.7%
126,651
+2.2%
0.01%
+8.3%
Q4 2022$10,988,613
+4.9%
123,969
-5.1%
0.01%0.0%
Q3 2022$10,471,000
+1.4%
130,606
+21.2%
0.01%
+9.1%
Q2 2022$10,323,000
-42.8%
107,796
-11.3%
0.01%
-26.7%
Q1 2022$18,046,000
+7.7%
121,487
+2.7%
0.02%
+66.7%
Q4 2021$16,762,000
+19.4%
118,252
+10.2%
0.01%
+12.5%
Q3 2021$14,042,000
+4.2%
107,332
+9.2%
0.01%
+14.3%
Q2 2021$13,474,000
+51.2%
98,267
+44.0%
0.01%
+40.0%
Q1 2021$8,913,000
+145.9%
68,250
+110.9%
0.01%
+150.0%
Q4 2020$3,625,000
+117.5%
32,368
+52.8%
0.00%
+100.0%
Q3 2020$1,667,000
+1.2%
21,180
-7.5%
0.00%0.0%
Q2 2020$1,648,000
+43.7%
22,886
+14.2%
0.00%0.0%
Q1 2020$1,147,000
-70.0%
20,032
-41.4%
0.00%
-66.7%
Q4 2019$3,825,000
+44.7%
34,207
+24.4%
0.00%
+50.0%
Q3 2019$2,644,000
+26.4%
27,507
+12.5%
0.00%0.0%
Q2 2019$2,091,000
-5.2%
24,445
-7.8%
0.00%0.0%
Q1 2019$2,205,000
-45.4%
26,514
-57.8%
0.00%
-50.0%
Q4 2018$4,036,000
+123.1%
62,875
+175.2%
0.00%
+100.0%
Q3 2018$1,809,000
-13.6%
22,849
-20.1%
0.00%0.0%
Q2 2018$2,093,000
+1.6%
28,605
-12.1%
0.00%0.0%
Q1 2018$2,060,000
+25.2%
32,531
+0.7%
0.00%
+100.0%
Q4 2017$1,646,000
-13.0%
32,316
-10.4%
0.00%
-50.0%
Q3 2017$1,892,000
+86.4%
36,070
+81.1%
0.00%
+100.0%
Q2 2017$1,015,000
-14.6%
19,913
-25.6%
0.00%0.0%
Q1 2017$1,189,000
-12.7%
26,771
-13.2%
0.00%0.0%
Q4 2016$1,362,000
+29.0%
30,828
+16.9%
0.00%0.0%
Q3 2016$1,056,000
-4.7%
26,380
+13.5%
0.00%0.0%
Q2 2016$1,108,000
+35.8%
23,234
+19.4%
0.00%0.0%
Q1 2016$816,000
+22.5%
19,466
+28.9%
0.00%0.0%
Q4 2015$666,000
-39.0%
15,107
-34.0%
0.00%0.0%
Q3 2015$1,092,000
+11.3%
22,894
+35.9%
0.00%0.0%
Q2 2015$981,000
+49.5%
16,851
+29.6%
0.00%0.0%
Q1 2015$656,000
-4.0%
12,998
-14.3%
0.00%0.0%
Q4 2014$683,000
-23.8%
15,169
-37.6%
0.00%0.0%
Q3 2014$896,000
-77.9%
24,299
-73.5%
0.00%
-66.7%
Q2 2014$4,049,000
+95.3%
91,703
+92.2%
0.00%
+50.0%
Q1 2014$2,073,000
+147.1%
47,717
+141.6%
0.00%
+100.0%
Q4 2013$839,000
-17.0%
19,748
-33.7%
0.00%0.0%
Q3 2013$1,011,000
+19.4%
29,794
+9.8%
0.00%0.0%
Q2 2013$847,000
+47.3%
27,142
+60.7%
0.00%0.0%
Q1 2013$575,00016,8900.00%
Other shareholders
CONMED CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders